Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 162
- −4 vs. Q2 2024
- Portfolio value
- $6.17B
- +$18.1M (+0.3%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DHRDanaher Corp | Stock | 105,590 | $29.4M | 0.5% | +21,670+25.8% | Added | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $30.5M | 0.5% | 00.0% | Unchanged | History |
| IQVIQVIA Holdings Inc. | Stock | 129,827 | $30.8M | 0.5% | +37,744+41.0% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 4,460,693 | $32.2M | 0.5% | −4,000−0.1% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,929,963 | $32.7M | 0.5% | −12,350−0.1% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 367,181 | $33.0M | 0.5% | −149,352−28.9% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 53,623 | $33.2M | 0.5% | +10,997+25.8% | Added | History |
| WVEWave Life Sciences, Inc. | SHS | 4,094,458 | $33.6M | 0.5% | 00.0% | Unchanged | History |
| GMEDGlobus Medical Inc | Stock | 469,798 | $33.6M | 0.5% | −27,495−5.5% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 163,512 | $34.3M | 0.6% | −5,071−3.0% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 1,220,059 | $35.1M | 0.6% | +85,830+7.6% | Added | History |
| CSTLCastle Biosciences Inc | COM | 1,262,030 | $36.0M | 0.6% | +44,929+3.7% | Added | History |
| ALGNAlign Technology Inc | COM | 143,996 | $36.6M | 0.6% | +140.0% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,517,839 | $37.1M | 0.6% | 00.0% | Unchanged | History |
| BEAMBeam Therapeutics Inc. | COM | 1,518,121 | $37.2M | 0.6% | +100,000+7.1% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 1,205,464 | $37.5M | 0.6% | +50,810+4.4% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,428,929 | $38.1M | 0.6% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 525,434 | $38.4M | 0.6% | −496,266−48.6% | Reduced | History |
| RMDResmed Inc | COM | 160,128 | $39.1M | 0.6% | +4,247+2.7% | Added | History |
| LLYEli Lilly & Co | Stock | 44,246 | $39.2M | 0.6% | −5,428−10.9% | Reduced | History |
| CICigna Group | Stock | 118,407 | $41.0M | 0.7% | −4,683−3.8% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 195,080 | $41.2M | 0.7% | +70,356+56.4% | Added | History |
| EXELExelixis, Inc. | COM | 1,600,000 | $41.5M | 0.7% | −203,200−11.3% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 344,348 | $43.0M | 0.7% | +92,027+36.5% | Added | History |
| COOCooper Companies, Inc. | COM | 397,373 | $43.8M | 0.7% | 00.0% | Unchanged | History |
| IDXXIDEXX Laboratories Inc | COM | 91,279 | $46.1M | 0.7% | −2,079−2.2% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 89,328 | $46.5M | 0.8% | −12,221−12.0% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 114,525 | $46.5M | 0.8% | −7,779−6.4% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 432,805 | $46.7M | 0.8% | −16,276−3.6% | Reduced | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,879,583 | $47.8M | 0.8% | −10,000−0.1% | Reduced | History |
| PRCTPROCEPT BioRobotics Corp | COM | 612,691 | $49.1M | 0.8% | −56,358−8.4% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 531,967 | $49.9M | 0.8% | +10,950+2.1% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 1,654,878 | $51.8M | 0.8% | +237,999+16.8% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 7,377,184 | $52.2M | 0.8% | +1,000,069+15.7% | Added | History |
| PENPenumbra Inc | COM | 272,683 | $53.0M | 0.9% | −9,366−3.3% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,386,600 | $58.8M | 1.0% | −4,200−0.2% | Reduced | History |
| DXCMDexcom Inc | COM | 1,017,038 | $68.2M | 1.1% | −251,649−19.8% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 1,134,076 | $74.8M | 1.2% | −126,385−10.0% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 2,670,050 | $75.5M | 1.2% | +1,000,215+59.9% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,850,891 | $78.5M | 1.3% | +307,624+19.9% | Added | History |
| BDXBecton Dickinson & Co | Stock | 337,633 | $81.4M | 1.3% | −9,700−2.8% | Reduced | History |
| MDTMedtronic plc | Stock | 1,008,633 | $90.8M | 1.5% | +6,886+0.7% | Added | History |
| PODDInsulet Corp | Stock | 421,479 | $98.1M | 1.6% | −13,941−3.2% | Reduced | History |
| CDNACareDx, Inc. | COM | 3,145,456 | $98.2M | 1.6% | −767,119−19.6% | Reduced | History |
| EXASExact Sciences Corp | COM | 1,449,465 | $98.7M | 1.6% | +290,585+25.1% | Added | History |
| BHVNBiohaven Ltd. | COM | 2,040,853 | $102.0M | 1.7% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,071,615 | $104.4M | 1.7% | +100,000+3.4% | Added | History |
| MRNAModerna, Inc. | Stock | 1,600,836 | $107.0M | 1.7% | +37,101+2.4% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 225,550 | $131.9M | 2.1% | +19,875+9.7% | Added | History |
| INCYIncyte Corp | COM | 2,150,551 | $142.2M | 2.3% | −2,953−0.1% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 3,735,915 | $166.0M | 2.7% | −143,633−3.7% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,485,627 | $181.9M | 2.9% | +14,342+0.6% | Added | History |
| SYKStryker Corp | Stock | 526,607 | $190.2M | 3.1% | −19,327−3.5% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,743,938 | $198.8M | 3.2% | +137,785+8.6% | Added | History |
| BSXBoston Scientific Corp | Stock | 2,452,797 | $205.5M | 3.3% | −116,791−4.5% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,863,800 | $214.7M | 3.5% | −34,840−1.8% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 4,871,360 | $220.9M | 3.6% | −157,740−3.1% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 809,095 | $222.5M | 3.6% | −110,739−12.0% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 496,775 | $244.1M | 4.0% | −43,129−8.0% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 571,406 | $265.7M | 4.3% | −22,055−3.7% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 7,874,400 | $315.4M | 5.1% | −386,034−4.7% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 632,829 | $343.0M | 5.6% | −59,045−8.5% | Reduced | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Summit Therapeutics Inc86627T908 | CALL | – | $219.0K |
Sold out since Q2 2024 (15)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| SILKSilk Road Medical Inc | COM | 855,293 | $23.1M | 0.4% | History |
| ATRCAtriCure, Inc. | COM | 212,559 | $4.84M | 0.1% | History |
| OMOutset Medical, Inc. | COM | 762,799 | $2.94M | <0.1% | History |
| TDOCTeladoc Health, Inc. | COM | 272,798 | $2.67M | <0.1% | History |
| NVRONevro Corp | COM | 135,235 | $1.14M | <0.1% | History |
| AAPLApple Inc. | Stock | 2,200 | $463.4K | <0.1% | History |
| ALKSAlkermes plc. | SHS | 18,000 | $433.8K | <0.1% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 15,700 | $329.5K | <0.1% | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 16,000 | $323.8K | <0.1% | History |
| DVAXDynavax Technologies Corp | COM NEW | 27,558 | $309.5K | <0.1% | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 57,600 | $266.1K | <0.1% | History |
| ETNB89bio, Inc. | COM | 24,700 | $197.8K | <0.1% | History |
| WSTWest Pharmaceutical Services Inc | COM | 520 | $171.3K | <0.1% | History |
| GRALGRAIL, Inc. | COM | 7,266 | $111.7K | <0.1% | History |
| Exscientia PLC30223G102 | ADS | 3,350 | $17.1K | <0.1% | – |